It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
GLUE’s FA Score shows that 1 FA rating(s) are green whilePEGA’s FA Score has 2 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
GLUE’s TA Score shows that 6 TA indicator(s) are bullish while PEGA’s TA Score has 3 bullish TA indicator(s).
GLUE (@Biotechnology) experienced а +6.86% price change this week, while PEGA (@Packaged Software) price change was -5.27% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was +4.82%. For the same industry, the average monthly price growth was +7.31%, and the average quarterly price growth was +2179.40%.
The average weekly price growth across all stocks in the @Packaged Software industry was +1.94%. For the same industry, the average monthly price growth was +3.67%, and the average quarterly price growth was +3.27%.
GLUE is expected to report earnings on Aug 06, 2026.
PEGA is expected to report earnings on Jul 29, 2026.
Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
@Packaged Software (+1.94% weekly)Packaged software comprises multiple software programs bundled together and sold as a group. For example, Microsoft Office includes multiple applications such as Excel, Word, and PowerPoint. In some cases, buying a bundled product is cheaper than purchasing each item individually[s20] . Microsoft Corporation, Oracle Corp. and Adobe are some major American packaged software makers.
| GLUE | PEGA | GLUE / PEGA | |
| Capitalization | 1.5B | 5.41B | 28% |
| EBITDA | -139.94M | 221M | -63% |
| Gain YTD | 13.202 | -45.748 | -29% |
| P/E Ratio | 49.25 | 17.49 | 282% |
| Revenue | 43M | 1.7B | 3% |
| Total Cash | 666M | 474M | 141% |
| Total Debt | 39.1M | 72.1M | 54% |
PEGA | ||
|---|---|---|
OUTLOOK RATING 1..100 | 62 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 18 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | |
SMR RATING 1..100 | 19 | |
PRICE GROWTH RATING 1..100 | 80 | |
P/E GROWTH RATING 1..100 | 97 | |
SEASONALITY SCORE 1..100 | 4 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| GLUE | PEGA | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 90% | 2 days ago 75% |
| Stochastic ODDS (%) | 2 days ago 89% | 2 days ago 71% |
| Momentum ODDS (%) | 2 days ago 82% | 2 days ago 81% |
| MACD ODDS (%) | 2 days ago 81% | 2 days ago 74% |
| TrendWeek ODDS (%) | 2 days ago 88% | 2 days ago 74% |
| TrendMonth ODDS (%) | 2 days ago 88% | 2 days ago 77% |
| Advances ODDS (%) | 6 days ago 88% | 17 days ago 67% |
| Declines ODDS (%) | 2 days ago 90% | 2 days ago 77% |
| BollingerBands ODDS (%) | 2 days ago 90% | 2 days ago 69% |
| Aroon ODDS (%) | 2 days ago 85% | 2 days ago 80% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| KXI | 68.38 | 0.07 | +0.10% |
| iShares Global Consumer Staples ETF | |||
| TEND | 27.20 | -0.03 | -0.10% |
| iShares Large Cap 10% Trgt Buffr Dec ETF | |||
| PTIN | 37.01 | -0.07 | -0.18% |
| Pacer Trendpilot International ETF | |||
| LLYX | 24.51 | -0.31 | -1.25% |
| Defiance Daily Target 2X Long LLY ETF | |||
| BRF | 16.80 | -0.37 | -2.18% |
| VanEck Brazil Small-Cap ETF | |||
A.I.dvisor indicates that over the last year, GLUE has been loosely correlated with CRNX. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if GLUE jumps, then CRNX could also see price increases.
| Ticker / NAME | Correlation To GLUE | 1D Price Change % | ||
|---|---|---|---|---|
| GLUE | 100% | -2.04% | ||
| CRNX - GLUE | 42% Loosely correlated | -0.34% | ||
| IMNM - GLUE | 38% Loosely correlated | -0.89% | ||
| AXON - GLUE | 38% Loosely correlated | -1.76% | ||
| RVMD - GLUE | 37% Loosely correlated | -2.17% | ||
| KURA - GLUE | 37% Loosely correlated | -1.42% | ||
More | ||||
A.I.dvisor indicates that over the last year, PEGA has been loosely correlated with HUBS. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if PEGA jumps, then HUBS could also see price increases.
| Ticker / NAME | Correlation To PEGA | 1D Price Change % | ||
|---|---|---|---|---|
| PEGA | 100% | -1.10% | ||
| HUBS - PEGA | 59% Loosely correlated | -1.73% | ||
| TTAN - PEGA | 57% Loosely correlated | -3.24% | ||
| CRM - PEGA | 57% Loosely correlated | -1.73% | ||
| FRSH - PEGA | 56% Loosely correlated | -0.10% | ||
| PCOR - PEGA | 56% Loosely correlated | -1.39% | ||
More | ||||